Unknown PHASE1 INTERVENTIONAL 2-arm NCT02260375

MSC Therapy in Liver Transplantation

THIRD-PARTY BONE MARROW-DERIVED MESENCHYMAL STROMAL CELLS TO INDUCE TOLERANCE IN LIVER TRANSPLANT RECIPIENTS

Sponsor: Mario Negri Institute for Pharmacological Research

Updated 6 times since 2017 Last updated: Apr 5, 2018 Started: Oct 31, 2014 Primary completion: Oct 31, 2024 Completion: Oct 31, 2025

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE1 clinical study on Liver Transplant Rejection, this trial is ongoing. The trial is conducted by Mario Negri Institute for Pharmacological Research and has accumulated 6 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Dec 2025 — Present [monthly]

Unknown PHASE1

Status: Recruiting → Unknown
Sep 2024 — Dec 2025 [monthly]

Recruiting PHASE1
Jul 2024 — Sep 2024 [monthly]

Recruiting PHASE1
Jan 2021 — Jul 2024 [monthly]

Recruiting PHASE1
Jun 2018 — Jan 2021 [monthly]

Recruiting PHASE1

▶ Show 1 earlier version

Jan 2017 — Jun 2018 [monthly]

Recruiting PHASE1

First recorded

Oct 2014

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Mario Negri Institute for Pharmacological Research
Monia Lorini

Data source: A.O. Ospedale Papa Giovanni XXIII

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Bergamo, Italy
• Bologna, Italy